FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Abdellah Ahnaou

Research Profile

Living Beings

Procedures

Physiology

Concepts & Ideas

Disorders

Sleep Stages

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Jose María Cid; Ana I De Lucas; W H I M Drinkenburg; David Gallacher; Aránzazu Garcia; Laura Iturrino; Hilde Lavreysen; María Lourdes Linares; Gregor J Macdonald; Claire Mackie; Encarna Matesanz; Anton Megens; Daniel Oehlrich; Stefan Pype; Abdellah Ahnaou; J Ignacio Andrés; Gary Tresadern; Juan Antonio Vega; Andrés A Trabanco
Discovery of 3-cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): a positive allosteric modulator of the metabotropic glutamate 2 receptor.
Pascal Bonaventure; Nicholas I Carruthers; Wenying Chai; Peter De Boer; Jianing Di; Wilhelmus Drinkenburg; Christine Dugovic; Curt A Dvorak; Lisa Dvorak; Ian Fraser; Michelle Kramer; Brian Lord; Diane Nepomuceno; Steve Sands; Jonathan Shelton; Jaskaran Singh; Sue Wilson; Abdellah Ahnaou; Leah Aluisio; Kirk Bertelsen; Timothy W Lovenberg
Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorder.
Abdellah Ahnaou; W H I M Drinkenburg
Neuropeptide-S evoked arousal with electroencephalogram slow-wave compensatory drive in rats.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Abdellah Ahnaou (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Jose María Cid; Ana I De Lucas; W H I M Drinkenburg; David Gallacher; Aránzazu Garcia; Laura Iturrino; Hilde Lavreysen; María Lourdes Linares; Gregor J Macdonald; Claire Mackie; Encarna Matesanz; Anton Megens; Daniel Oehlrich; Stefan Pype; Abdellah Ahnaou; J Ignacio Andrés; Gary Tresadern; Juan Antonio Vega; Andrés A Trabanco
Discovery of 3-cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): a positive allosteric modulator of the metabotropic glutamate 2 receptor.
Journal of medicinal chemistry 2012;55(20):8770-89.
2012: Pascal Bonaventure; Nicholas I Carruthers; Wenying Chai; Peter De Boer; Jianing Di; Wilhelmus Drinkenburg; Christine Dugovic; Curt A Dvorak; Lisa Dvorak; Ian Fraser; Michelle Kramer; Brian Lord; Diane Nepomuceno; Steve Sands; Jonathan Shelton; Jaskaran Singh; Sue Wilson; Abdellah Ahnaou; Leah Aluisio; Kirk Bertelsen; Timothy W Lovenberg
Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorder.
The Journal of pharmacology and experimental therapeutics 2012;342(2):429-40.
2012: Abdellah Ahnaou; W H I M Drinkenburg
Neuropeptide-S evoked arousal with electroencephalogram slow-wave compensatory drive in rats.
Neuropsychobiology 2012;65(4):195-205.
2012: Abdellah Ahnaou; Shigeyuki Chaki; Annick Heylen; Ludo Kennis; Atsuro Nakazato; Thomas Steckler; W H I M Drinkenburg
R278995/CRA0450, a corticotropin-releasing factor (CRF(1)) receptor antagonist modulates REM sleep measures in rats: Implication for therapeutic indication.
European journal of pharmacology 2012;680(1-3):63-8.
2010: Kristien Wouters; Jose Cortinas Abrahantes; Geert Molenberghs; Helena Geys; Abdellah Ahnaou; Wilhelmus H I M Drinkenburg; Luc Bijnens
Correction for model selection bias using a modified model averaging approach for supervised learning methods applied to EEG experiments.
Journal of biopharmaceutical statistics 2010;20(4):768-86.
2009: Sibah Hasan; Sylvain Pradervand; Abdellah Ahnaou; Wilhelmus Drinkenburg; Mehdi Tafti; Paul Franken
How to keep the brain awake? The complex molecular pharmacogenetics of wake promotion.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(7):1625-40.
2009: Abdellah Ahnaou; Frank M Dautzenberg; Helena Geys; Hassan Imogai; Antoine Gibelin; Dieder Moechars; Thomas Steckler; Wilhelmus H I M Drinkenburg
Modulation of group II metabotropic glutamate receptor (mGlu2) elicits common changes in rat and mice sleep-wake architecture.
European journal of pharmacology 2009;603(1-3):62-72.
2008: Abdellah Ahnaou; W H I M Drinkenburg; Adriaan Bouwknecht; Jesus Alcazar; Thomas Steckler; Frank M Dautzenberg
Blocking melanin-concentrating hormone MCH1 receptor affects rat sleep-wake architecture.
European journal of pharmacology 2008;579(1-3):177-88.
2008: Kristien Wouters; Jose Cortinas Abrahantes; Geert Molenberghs; Abdellah Ahnaou; Wilhelmus H I M Drinkenburg; Luc Bijnens
A comparison of doubly hierarchical discriminant analyses for multiple class longitudinal data from EEG experiments.
Journal of biopharmaceutical statistics 2008;18(6):1120-35.
2007: Abdellah Ahnaou; S Nayak; A Heylen; David Ashton; W H I M Drinkenburg
Sleep and EEG profile in neonatal hippocampal lesion model of schizophrenia.
Physiology & behavior 2007;92(3):461-7.
2007: Marian Geldof; Jan Freijer; Ludy Van Beijsterveldt; Philip Timmerman; Abdellah Ahnaou; W H I M Drinkenburg; Meindert Danhof
Population pharmacokinetic model of fluvoxamine in rats: utility for application in animal behavioral studies.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2007;30(1):45-55.
2003: Vesa K Kontinen; Abdellah Ahnaou; W H I M Drinkenburg; Theo F Meert
Sleep and EEG patterns in the chronic constriction injury model of neuropathic pain.
Physiology & behavior 2003;78(2):241-6.
2003: Abdellah Ahnaou; Anton Megens; W H I M Drinkenburg
The atypical antipsychotics risperidone, clozapine and olanzapine differ regarding their sedative potency in rats.
Neuropsychobiology 2003;48(1):47-54.